- MEP Lola Sánchez questions the European Commission: EU's position on the UN High-Level Panel on Access to Medicines at WIPO
- WTO TRIPS Council: Brazilian submission on Ecommerce and Copyright
- All 12 Zhang/Broad Institute CRISPR patents declare US funding and rights in inventions
- KEI Comments filed in USTR Special 301 Review
- WTO Trade Policy Review: Members question the United States on compulsory licensing, Bayh-Dole, UNHLP & Section 337
- EB140: WHO adopts decision on terms of reference for overall programme review of the GSPOA (31 Jan 2017)
- EB140 heats up during discussions of proposed changes to resolution on TOR of Overall Programme Review of GSPOA
- Feb 24, 2017 - U.S. History, Experiences, and Prospects of Compulsory Licensing of Medical Patents
- Chilean Cámara de Diputados votes overwhelmingly to advance compulsory licensing of drug patents.
- EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines
EB130: CMC Churches' Action for Health intervention on the Consultative Expert Working Group on Research and Development (CEWG)Submitted by thiru on 21. January 2012 - 9:08
This was the statement delivered by CMC Churches' Action for Health intervention on 21 January 2012 on the Consultative Expert Working Group on Research and Development: Financing and Coordination at the 130th WHO Executive Board meeting.
CMC Churches' Action for Health intervention on the Consultative Expert Working Group on Research
and Development: Financing and Coordination at the 130th WHO Executive Board meeting
WHO 130th Executive Board Agenda Item 6.14
Intervention by James Love, CMC Churches' Action for Health
Since May 2009, the ACLU and Public Patent Foundation (PUBPAT) have been litigating a case involving the patent eligibility of two human genes, BRCA1 and BRCA2, associated with ovarian and breast cancer. ACLU and PUBPAT, representing the petitioners, Association for Molecular Pathology, among others, have argued that human genes are not patentable and that patents on such objects stifle diagnostic testing and further research.
For call-in details for today's event, contact Krista Cox.
On January 27, 2012, KEI will host a brown bag lunch with Shira Perlmutter. Shira was recently appointed the Administrator for Policy and External Affairs of USPTO. This position was most recently held by Albert Tramposch, who replaced Arti Rai, the first Obama appointee.
WHO reform efforts to consider new modalities for engagement with NGOs, foundations, partnerships and for-profit-organizationsSubmitted by thiru on 11. January 2012 - 5:02
WHO reform is among the hot topics for consideration at the 130th session of the WHO Executive Board which meets from 16 January 2012 to 23 January 2012. One paper in particular, EB130/5 Add.4, entitled, "Governance: Promoting engagement with other stakeholders and involvement with and oversight of partnerships" describes how WHO may re-assess its relationship with non-governmental organizations including,
Response to Federal Register notice seeking comments regarding Canada's interest in TPPA negotiationsSubmitted by Krista Cox on 10. January 2012 - 17:18
On December 7, 2011, USTR issued Federal Register Notice 76480-76481 requesting comments on "Canada's Expression of Interest in the Proposed Trans-Pacific Partnership Trade Agreement." USTR issued similar requests for comments regarding Japan's (Notice 76478-76479) and Mexico's (Notice 76479-76480) expression of interest in the TPPA.
KEI has submitted a response to this notice available for download here.
World Health Organization
The 130th session of the WHO Executive Board will examine inter alia, the following technical items:
Prevention and control of noncommunicable diseases (scheduled for discussion on Thursday, 19 January 2012)
On December 16, 2011, H.R. 3699, "the Research Works Act", was introduced by Rep. Darrell Issa (R-CA), Chairman of the Committee on Oversight and Government Reform, and Committee member Rep. Carolyn Maloney (D-NY). This is how the Association of American Publishers describes the bill:
KEI comments for House Committee on Ways and Means Hearing on Trans-Pacific Partnership Agreement (TPPA)Submitted by Krista Cox on 28. December 2011 - 16:41
On Wednesday, December 14, 2011 the Subcommittee on Trade of the Committee on Ways and Means held a hearing on the Trans-Pacific Partnership Agreement (TPPA). Oral testimony was accepted only from invited witnesses. These witnesses included: Ambassador Demetrios Marantis (Deputy U.S. Trade Representative), Devry S. Boughner (Director, Intenrational Business Relations on behalf of Cargill Inc. and U.S. Business Coalition for TPP), Angela Marshall Hofmann (Vice President for Global Integrated Sourcing on Trade, Wal-Mart Stores), and Michael Wessel (President of The Wessel Group).
On June 11, 2011, KEI published KEI Policy Brief 2011:1, which was titled: "White House and European Commission trade official oppose waiver of drug patents for Least Developed Countries (LDCs)."
16 December 2011: KEI side event @ 8th WTO Ministerial Conference: The TRIPS Agreement and CopyrightSubmitted by thiru on 12. December 2011 - 8:07
Friday, 16 December 2011
Knowledge Ecology International (KEI) side event @ 8th WTO Ministerial Conference
Room B, Centre William Rappard, World Trade Organization
Rue de Lausanne 154
11:00 AM to 1:00 PM
The TRIPS Agreement and Copyright
Knowledge Ecology International
TRIPS, the copyright 3-step test, and exceptions to rights
WIPO Standing Committee on the Law of Patents: Obama Administration's proposal on patents and healthSubmitted by thiru on 8. December 2011 - 1:51
On Wednesday, 7 December 2011, the United States of America tabled a proposal on patents and health which was distributed at 6 PM by the WIPO Secretariat after much of the substantive dicussions
Standing Committee on the Law of Patents
Geneva, December 5 to 9, 2011
PATENTS AND HEALTH: PROPOSAL BY THE DELEGATION OF THE UNITED STATES OF AMERICA
Document prepared by the Secretariat
Statement of Knowledge Ecology International (KEI) to the WIPO Standing Committee on the Law of Patents (SCP): Patents and Health
7 December 2011
Thank you Mr. Chair. Knowledge Ecology International has submitted its written comments on patents and health which can be found in WIPO document SCP/17/INF/3.
WIPO patent committee: Statement of Group B (industrialized countries) at WIPO on discussions of patents and healthSubmitted by thiru on 7. December 2011 - 5:57
The United States, on behalf of Group B (which includes Western European countries, Norway, the United States, Switzerland, Japan, Canada, New Zealand, Australia, Turkey, Israel and the Holy See) presented the following statement opposing the adoption of the African Group/Development Agenda Group on patents and health (in its current forum). In its individual intervention, the Holy See supported the African Group/Development Agenda Group proposal.
With respect to broadcasting, KEI reiterates its opposition to work at WIPO on a new treaty for broadcasting organizations.
When governments grant intellectual property rights to broadcasting organizations, they undermine the rights of copyright holders, and reduce the incomes of creative communities.